menu
    • menu

    Find Treprostinil Sodium manufacturers, exporters & distributors on PharmaCompass

    Chirogate Treprostinil Sodium

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    Nuray Treprostinil Sodium

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    21

    API Suppliers

    API Suppliers

    14

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    0

    KDMF

    KDMF

    12

    NDC API

    NDC API

    0

    VMF

    NDC API

    13

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 383,357

    MARKET PLACE

    4

    API

    2

    FDF

    4INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    73

    FDF Dossiers

    FDF Dossiers

    40

    FDA Orange Book

    FDA (Orange Book)

    25

    Europe

    Europe

    4

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    4

    Listed Dossiers

    Listed Dossiers

    42DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    115

    US Patents

    5

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    63

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    11,464,786

    Annual Reports

    6,227

    Finished Drug Prices

    Listed Dossiers

    70 RELATED EXCIPIENT COMPANIES

    124EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 81846-19-7, Remodulin, Uniprost, Rumodolin, Orenitram, Tyvaso
    Molecular Formula
    C23H34O5
    Molecular Weight
    390.5  g/mol
    InChI Key
    PAJMKGZZBBTTOY-ZFORQUDYSA-N
    FDA UNII
    RUM6K67ESG
    Treprostinil Sodium
    Treprostinil is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension.
    Treprostinil is a Prostacycline Vasodilator. The physiologic effect of treprostinil is by means of Vasodilation.
    1 2D Structure

    Treprostinil Sodium

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
    2.1.2 InChI
    InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1
    2.1.3 InChI Key
    PAJMKGZZBBTTOY-ZFORQUDYSA-N
    2.1.4 Canonical SMILES
    CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
    2.1.5 Isomeric SMILES
    CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    RUM6K67ESG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. ((1r,2r,3as,9as)-2-hydroxy-1-((3s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cylopent(b)naphthalen-5-yl)oxy)acetate

    2. Orenitram

    3. Remodulin

    4. Trepostinil Sodium

    5. Treprostinil Diethanolamine

    6. Treprostinil Diolamin

    7. Treprostinil Diolamine

    8. Treprostinil Sodium

    9. Ut-15

    10. Ut-15c

    2.3.2 Depositor-Supplied Synonyms

    1. 81846-19-7

    2. Remodulin

    3. Uniprost

    4. Rumodolin

    5. Orenitram

    6. Tyvaso

    7. Lrx-15

    8. Ut-15

    9. 15au81

    10. Treprostinil Free Acid

    11. Rum6k67esg

    12. 2-(((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yl)oxy)acetic Acid

    13. Chebi:50861

    14. 81846-19-7 (free Acid)

    15. ((1r,2r,3as,9as)-2-hydroxy-1-((3s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cylopent(b)naphthalen-5-yl)oxy)acetate

    16. 2-[[(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[g]naphthalen-5-yl]oxy]acetic Acid

    17. 289480-64-4

    18. 15-au-81

    19. L-606

    20. Treprostinilo

    21. Treprostinilum

    22. Lrx 15

    23. Treprostinil [usan:inn]

    24. Remodulin (tn)

    25. Unii-rum6k67esg

    26. U 62840

    27. Tresprostinil

    28. Trevyent

    29. U-62,840

    30. Treprostinil [mi]

    31. Treprostinil [inn]

    32. Treprostinil [jan]

    33. Treprostinil [usan]

    34. Treprostinil [vandf]

    35. Treprostinil Pound>>ut-15

    36. Treprostinil [mart.]

    37. Treprostinil [who-dd]

    38. 15au

    39. Gtpl5820

    40. Schembl4349618

    41. Treprostinil (jan/usan/inn)

    42. Chembl1237119

    43. Lrx -15

    44. Dtxsid901021654

    45. Hms3648g07

    46. Treprostinil [orange Book]

    47. Amy22230

    48. Bcp10253

    49. Ex-a1414

    50. Zinc3800475

    51. Mfcd00888847

    52. Akos027470173

    53. Cs-7872

    54. Db00374

    55. Ncgc00343944-03

    56. ({(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yl}oxy)acetic Acid

    57. 2-[[(1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]acetic Acid

    58. Ac-30207

    59. As-56364

    60. L606

    61. Hy-100441

    62. D06213

    63. Sr-01000946210

    64. Q3495231

    65. Sr-01000946210-1

    66. Brd-k19706299-001-01-4

    67. [[(1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(s)-3-hydroxyoctyl]-1h-benzo[f]indene-5-yl]oxy]acetic Acid

    68. [[(1r,2r,3as,9as)-2,3,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]acetic Acid

    69. 2-((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[b]naphthalen-5-yloxy)acetic Acid

    70. 2-[[(1r,2r,3as,9as)-2,3,4,9,9a-hexahydro-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h-benz[f]inden-5-yl]oxy]-acetic Acid

    71. 2-[[(2r,3r,3as,9as)-2-hydroxy-3-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[g]naphthalen-8-yl]oxy]acetic Acid

    72. 2-{[(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-1h,2h,3h,3ah,4h,9h,9ah-cyclopenta[b]naphthalen-5-yl]oxy}acetic Acid

    73. Acetic Acid, (((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-

    74. Acetic Acid, ((2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-(3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, (1r-(1alpha(s*),2beta,3aalpha,9aalpha))-

    75. Acetic Acid,(((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 390.5 g/mol
    Molecular Formula C23H34O5
    XLogP34.5
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count10
    Exact Mass390.24062418 g/mol
    Monoisotopic Mass390.24062418 g/mol
    Topological Polar Surface Area87 Ų
    Heavy Atom Count28
    Formal Charge0
    Complexity495
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameRemodulin
    PubMed HealthTreprostinil
    Drug ClassesAntihypertensive, Cardiovascular Agent, Platelet Aggregation Inhibitor, Vasodilator
    Drug LabelRemodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for subcutaneous or intravenous administration. Remodulin is supplied in 20 mL multidose vials in four strengths, containing 20 mg, 50 mg, 100 mg, or 200 mg (1 mg/mL,...
    Active IngredientTreprostinil
    Dosage FormInjectable
    RouteIv (infusion), subcutaneous
    Strength1mg/ml; 2.5mg/ml; 10mg/ml; 5mg/ml
    Market StatusPrescription
    CompanyUnited Therap

    2 of 4  
    Drug NameTyvaso
    PubMed HealthTreprostinil (By breathing)
    Drug ClassesVasodilator
    Drug LabelTyvaso is a sterile formulation of treprostinil intended for administration by oral inhalation using the Tyvaso Inhalation System. Tyvaso is supplied in 2.9 mL low density polyethylene (LDPE) ampules, containing 1.74 mg treprostinil (0.6 mg/mL). Each...
    Active IngredientTreprostinil
    Dosage FormSolution
    RouteInhalation
    Strengtheq 0.6mg base/ml
    Market StatusPrescription
    CompanyUnited Therap

    3 of 4  
    Drug NameRemodulin
    PubMed HealthTreprostinil
    Drug ClassesAntihypertensive, Cardiovascular Agent, Platelet Aggregation Inhibitor, Vasodilator
    Drug LabelRemodulin (treprostinil) Injection is a sterile solution of treprostinil formulated for subcutaneous or intravenous administration. Remodulin is supplied in 20 mL multidose vials in four strengths, containing 20 mg, 50 mg, 100 mg, or 200 mg (1 mg/mL,...
    Active IngredientTreprostinil
    Dosage FormInjectable
    RouteIv (infusion), subcutaneous
    Strength1mg/ml; 2.5mg/ml; 10mg/ml; 5mg/ml
    Market StatusPrescription
    CompanyUnited Therap

    4 of 4  
    Drug NameTyvaso
    PubMed HealthTreprostinil (By breathing)
    Drug ClassesVasodilator
    Drug LabelTyvaso is a sterile formulation of treprostinil intended for administration by oral inhalation using the Tyvaso Inhalation System. Tyvaso is supplied in 2.9 mL low density polyethylene (LDPE) ampules, containing 1.74 mg treprostinil (0.6 mg/mL). Each...
    Active IngredientTreprostinil
    Dosage FormSolution
    RouteInhalation
    Strengtheq 0.6mg base/ml
    Market StatusPrescription
    CompanyUnited Therap

    4.2 Drug Indication

    For use as a continuous subcutaneous infusion or intravenous infusion (for those not able to tolerate a subcutaneous infusion) for the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise.

    FDA Label

    Treatment of adult patients with WHO Functional Class (FC) III or IV and:

    - inoperable chronic thromboembolic pulmonary hypertension (CTEPH), or

    - persistent or recurrent CTEPH after surgical treatment

    to improve exercise capacity.

    Treatment of pulmonary arterial hypertension

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Pulmonary arterial hypertension (PAH) is a disease in which blood pressure is abnormally high in the arteries between the heart and lungs. PAH is characterized by symptoms of shortness of breath during physical exertion. The condition can ultimately lead to heart failure. Treprostinil is a potent oral antiplatelet agent. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. In animals, the vasodilatory effects reduce right and left ventricular afterload and increase cardiac output and stroke volume. Other studies have shown that treprostinil causes a dose-related negative inotropic and lusitropic effect. No major effects on cardiac conduction have been observed.

    5.2 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    TREPROSTINIL
    5.3.2 FDA UNII
    RUM6K67ESG
    5.3.3 Pharmacological Classes
    Prostaglandins I [CS]; Vasodilation [PE]; Prostacycline Vasodilator [EPC]
    5.4 ATC Code

    B01AC21

    B - Blood and blood forming organs

    B01 - Antithrombotic agents

    B01A - Antithrombotic agents

    B01AC - Platelet aggregation inhibitors excl. heparin

    B01AC21 - Treprostinil

    5.5 Absorption, Distribution and Excretion

    Absorption

    Relatively rapid and complete after subcutaneous infusion, with an absolute bioavailability approximately 100%. In patients with mild (n=4) or moderate (n=5) hepatic insufficiency and portopulmonary hypertension following a subcutaneous dose of 10 ng per kg of body weight per min for 150 mins the AUC 0-∞ was increased 3-fold and 5-fold respectively.

    Volume of Distribution

    14 L/70 kg

    5.6 Metabolism/Metabolites

    Substantially metabolized by the liver, but the precise enzymes responsible are unknown. Five metabolites have been described (HU1 through HU5) however, the biological activity and metabolic fate of these are unknown. The chemical structure of HU1 is unknown. The metabolite HU5 is the glucuronide conjugate of treprostinil. The other metabolites are formed by oxidation of the 3-hydroxyoctyl side chain (HU2) and subsequent additional oxidation (HU3) or dehydration (HU4). Study results of in vitro human hepatic cytochrome P450 demonstrates that treprostinil does not inhibit CYP-1A2, 2C9, 2C19, 2D6, 2E1, or 3A. There have been no studies that evaluate the potential of treprostinil to induce these enzymes.

    5.7 Biological Half-Life

    Terminal elimination half-life is approximately 2 to 4 hours. Plasma half-life is 34 and 85 minutes for intravenous and subcutaneous infusion of the drug, respectively.

    5.8 Mechanism of Action

    The major pharmacological actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and inhibition of platelet aggregation. In addition to treprostinil's direct vasodilatory effects, it also inhibits inflammatory cytokine. As a synthetic analogue of prostacyclin, it binds to the prostacyclin receptor, which subsequently induces the aforementioned downstream effects.

    API SUPPLIERS

    read-more
    read-more

    01

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28340

    Submission : 2016-08-15

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 68245-0008

    Start Marketing Date : 2010-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Nuray Chemicals Private Limited

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-02-16

    Pay. Date : 2016-09-20

    DMF Number : 30861

    Submission : 2016-09-27

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2024-02-20

    Valid Till : 2026-12-06

    Written Confirmation Number : WC-0416

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 58159-040

    Start Marketing Date : 2016-06-14

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (35kg/35kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Nuray Chemicals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ChemWerth Inc

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    VMX
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Chemwerth Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    EUROAPI

    France

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    NextGen Biomed
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-05-23

    Pay. Date : 2016-11-25

    DMF Number : 31145

    Submission : 2016-12-09

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 82231-115

    Start Marketing Date : 2019-11-28

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    EUROAPI Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #9.1B48
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2016-07-06

    Pay. Date : 2016-06-10

    DMF Number : 30106

    Submission : 2016-01-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HRV Global Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU arrow-down
    ✖
    Available Reg Filing : AU
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-01-06

    Pay. Date : 2014-07-15

    DMF Number : 28458

    Submission : 2014-09-16

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 68245-0008

    Start Marketing Date : 2010-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Chirogate International

    Taiwan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29207

    Submission : 2015-08-12

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 68245-0008

    Start Marketing Date : 2010-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1g/g)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Mannkind

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Biotech Showcase
    Not Confirmed
    arrow

    Mannkind

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Biotech Showcase
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 33169

    Submission : 2018-10-17

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Chirogate International Inc

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 28340

    Submission : 2016-08-15

    Status : Active

    Type : II

    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Chirogate International Inc

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29207

    Submission : 2015-08-12

    Status : Active

    Type : II

    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Chirogate International Inc

    Taiwan
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2015-01-06

    Pay. Date : 2014-07-15

    DMF Number : 28458

    Submission : 2014-09-16

    Status : Active

    Type : II

    Chirogate CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Ss Pharma Llc

    India
    arrow
    Duphat
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-02-16

    Pay. Date : 2016-09-20

    DMF Number : 30861

    Submission : 2016-09-27

    Status : Active

    Type : II

    Nuray Chemicals

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Euroapi Hungary Ltd

    France
    arrow
    NextGen Biomed
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-05-23

    Pay. Date : 2016-11-25

    DMF Number : 31145

    Submission : 2016-12-09

    Status : Active

    Type : II

    EUROAPI Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dr Reddys Laboratories Ltd

    India
    arrow
    CPhI WW Frankfurt
    Booth #9.1B48
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2016-07-06

    Pay. Date : 2016-06-10

    DMF Number : 30106

    Submission : 2016-01-12

    Status : Active

    Type : II

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Duphat
    Not Confirmed

    07

    Eurofins Cdmo Alphora Inc

    Canada
    arrow
    Duphat
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 25548

    Submission : 2011-12-01

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Duphat
    Not Confirmed

    08

    Msn Laboratories Private Ltd

    India
    arrow
    Duphat
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31450

    Submission : 2017-02-28

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Duphat
    Not Confirmed

    09

    Msn Laboratories Private Ltd

    India
    arrow
    Duphat
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 31573

    Submission : 2017-03-30

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Upjohn Co

    U.S.A

    USDMF

    arrow
    Duphat
    Not Confirmed

    10

    Upjohn Co

    U.S.A
    arrow
    Duphat
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 6804

    Submission : 1987-02-02

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1616524200,"product":"PHARMACEUTICAL RAW MATERIAL TREPROSTINIL","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"EMCURE PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"LAB ASPEN S.A","customerCountry":"ARGENTINA","quantity":"0.01","actualQuantity":"10","unit":"GMS","unitRateFc":"740","totalValueFC":"7252.6","currency":"USD","unitRateINR":52800,"date":"24-Mar-2021","totalValueINR":"528000","totalValueInUsd":"7252.6","indian_port":"BOMBAY AIR","hs_no":"29182110","bill_no":"9600854","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"T-184, MIDC, BHOSARI,PUNE, PUNE-MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630002600,"product":"TREPROSTINIL","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"LGM PHARMA","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"2550312.3","totalValueFC":"12387.5","currency":"USD","unitRateINR":183750000,"date":"27-Aug-2021","totalValueINR":"918750","totalValueInUsd":"12387.5","indian_port":"HYDERABAD AIR","hs_no":"29141990","bill_no":"4166409","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649356200,"product":"TREPROSTINIL SODIUM (BATCH NO:TPSRD21000","address":"25, 12TH CROSS STREET, SHASTRI NAGAR,","city":"CHENNAI\/TAMILNADU","supplier":"NURAY CHEMICALS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"THE PURCHASE MANAGER","customerCountry":"ARGENTINA","quantity":"0.25","actualQuantity":"0.25","unit":"KGS","unitRateFc":"175000","totalValueFC":"43552.6","currency":"USD","unitRateINR":13144000,"date":"08-Apr-2022","totalValueINR":"3286000","totalValueInUsd":"43552.6","indian_port":"BANGALORE AIR","hs_no":"29420090","bill_no":"9563842","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"25, 12TH CROSS STREET, SHASTRI NAGAR,, CHENNAI\/TAMILNADU","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696962600,"product":"TREPROSTINIL SODIUM (ALONG WITH WS 400 MG & TREPROSTINIL DIOLAMINE -ENATIOMER MIXTURE 20 MG)","address":"H.NO.-39, BAI KA BAGH","city":"ALLAHABAD. U.P","supplier":"I ON CORP.","supplierCountry":"INDIA","foreign_port":"BOGOTA","customer":"TO THE ORDER OF","customerCountry":"COLOMBIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"460","totalValueFC":"40586.7","currency":"USD","unitRateINR":33780,"date":"11-Oct-2023","totalValueINR":"3378000","totalValueInUsd":"40586.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4545643","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"COLOMBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"H.NO.-39, BAI KA BAGH, ALLAHABAD. U.P","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655145000,"product":"TREPROSTINIL","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,","city":"HYDERABAD,TELANGANA","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"UNITED KINGDOM","foreign_port":"N\/A","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.61","actualQuantity":"614","unit":"GMS","unitRateFc":"1169.1","totalValueFC":"722300.9","currency":"USD","unitRateINR":"91776.1","date":"14-Jun-2022","totalValueINR":"56350516","totalValueInUsd":"722300.9","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29420090","bill_no":"1000883","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696271400,"product":"TREPROSTINIL LH15163S02","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DR. REDDY\\'S LABORATORIES","supplierCountry":"UNITED KINGDOM","foreign_port":"N\/A","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"1.45","actualQuantity":"1447","unit":"GMS","unitRateFc":"757","totalValueFC":"1106188.2","currency":"USD","unitRateINR":"63626.3","date":"03-Oct-2023","totalValueINR":"92067269","totalValueInUsd":"1106188.2","indian_port":"Vizag-EPZ\/SEZ","hs_no":"29420090","bill_no":"1001833","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"}]
    24-Mar-2021
    11-Oct-2023
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Coating Systems & Additives

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Treprostinil Sodium Manufacturers

    A Treprostinil Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Treprostinil Sodium, including repackagers and relabelers. The FDA regulates Treprostinil Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Treprostinil Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Treprostinil Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Treprostinil Sodium Suppliers

    A Treprostinil Sodium supplier is an individual or a company that provides Treprostinil Sodium active pharmaceutical ingredient (API) or Treprostinil Sodium finished formulations upon request. The Treprostinil Sodium suppliers may include Treprostinil Sodium API manufacturers, exporters, distributors and traders.

    click here to find a list of Treprostinil Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Treprostinil Sodium USDMF

    A Treprostinil Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Treprostinil Sodium active pharmaceutical ingredient (API) in detail. Different forms of Treprostinil Sodium DMFs exist exist since differing nations have different regulations, such as Treprostinil Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Treprostinil Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Treprostinil Sodium USDMF includes data on Treprostinil Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Treprostinil Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Treprostinil Sodium suppliers with USDMF on PharmaCompass.

    Treprostinil Sodium WC

    A Treprostinil Sodium written confirmation (Treprostinil Sodium WC) is an official document issued by a regulatory agency to a Treprostinil Sodium manufacturer, verifying that the manufacturing facility of a Treprostinil Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Treprostinil Sodium APIs or Treprostinil Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Treprostinil Sodium WC (written confirmation) as part of the regulatory process.

    click here to find a list of Treprostinil Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

    Treprostinil Sodium NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Treprostinil Sodium as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Treprostinil Sodium API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Treprostinil Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Treprostinil Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Treprostinil Sodium NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Treprostinil Sodium suppliers with NDC on PharmaCompass.

    Treprostinil Sodium GMP

    Treprostinil Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Treprostinil Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Treprostinil Sodium GMP manufacturer or Treprostinil Sodium GMP API supplier for your needs.

    Treprostinil Sodium CoA

    A Treprostinil Sodium CoA (Certificate of Analysis) is a formal document that attests to Treprostinil Sodium's compliance with Treprostinil Sodium specifications and serves as a tool for batch-level quality control.

    Treprostinil Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Treprostinil Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Treprostinil Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Treprostinil Sodium EP), Treprostinil Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Treprostinil Sodium USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search